Thomas Schirrmann

Thomas Schirrmann has a diverse work experience spanning several roles and companies. Thomas started their career in 1997 as a Scientist at the Max Delbrück Center. Thomas then worked as a Promotion at Charité from 2001 to 2004. In 2005, they joined TU Braunschweig as a Research Group Leader, where they stayed until 2013. From 2013 onwards, they served as the CEO of YUMAB GmbH. In 2020, they became the CEO of Corat Therapeutics GmbH before assuming the role of Chief Operating Officer at Corat Therapeutics later that year.

Thomas Schirrmann received their PhD in Immunology from Humboldt-Universität zu Berlin in 2004. Prior to that, they obtained a Diplom in Biochemistry from the same institution.